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Abstract
Objective This paper oﬀers ‘consumer-led’ reﬂections by steering
group members of a patient-centred research study involving
consumer advocates, patients’ associations and patients, throughout
the whole study, from pre- to post-study phases.
Original Study Design The study: ‘Shared decision making and risk
communication in general practice’ incorporated systematic reviews,
psychometric evaluation of outcome measures, and quantitative,
qualitative and health economic analyses of a cluster randomized
trial of professional skill development, all informed by consumer
and patient engagement.
Setting and participants The work was produced by a wide
collaboration led by researchers from the Department of General
Practice, University of Wales College of Medicine, Cardiﬀ, including
a consumers’ advisory group and a patients’ association. The study
participants were 20 general practitioners from Gwent, their practice
staﬀ, and almost 800 patients at these practices.
Discussion Consumers and patients contributed to several stages of
the research from inception and design, securing of funding,
implementation of the protocol, and interpretation and dissemin-
ation of the ﬁndings. ‘Patient involvement’ research initiatives that
include an equally wide variety of ‘user’ participants as ‘health-
professional’ participants, accountable to a ‘Health in Partnership’
funded project, require a user-led viewpoint to be presented and
disseminated. This paper presents reﬂections on the processes of the
research, the interpretations of study ﬁndings by the involved
parties, and notes how this model is fundamental to eﬀective
research in the ﬁeld of patient-centred health care if future practice,
policy and research are to change.
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Introduction
The consultation – ‘The clinical encounter – the
focal point of patient – centred care’1 is the
pivotal experience in the provision of health care
to citizens and patients (our understanding of
these and various related terms used in this piece
is given in Box 1). The National Health Service
(NHS) generates around 250 million consulta-
tions every year.2 Determining exactly what is a
‘successful encounter and how it is to be
accomplished’ is therefore a critical question.
How should ‘success’ be considered and deﬁned,
and by whom? Who should establish the cri-
teria? In the UK, the general practitioner (GP) is
the gateway for citizens seeking health care: their
experience in the consultation is crucial for their
satisfaction, other process outcomes, general
well-being and future care. Understanding what
expectations patients have, and the components
that will enable health-care professionals to
negotiate a satisfactory outcome, are obviously
important, not just to the two parties involved at
the time, but to inform and direct the provision
of optimal and equitable health-care services
generally, including the training of health pro-
fessionals. An unsatisfactory consultation is a
bad beginning: it has the potential to adversely
aﬀect ensuing encounters, continuity of satis-
factory care there or elsewhere, or accomplish-
ment of satisfactory decisions to deal with the
individual patient’s health problem and concerns
in the context of their own circumstances, values
and preferences.
These questions arise in a broader context of
ethical and conceptual developments. There are
debates about the balance between personal
autonomy and social responsibility3 with
attempts to deﬁne a new kind of relationship or
even equality between the health-care profession
and consumers. These occur in a system that
also promotes evidence-based health care –
which may beneﬁt populations more than indi-
viduals, and therefore creates tensions.4 ‘Shared
decision making’ (SDM) has been proposed as a
model that can address some of these competing
tensions in real life, but it also means diﬀerent
things to diﬀerent people – both professionals
and consumers. It is also diﬃcult to put into
practice: weighing up the harms and beneﬁts of
diﬀerent options of a healthcare decision is
challenging, even if they are known and under-
stood. Professionals ﬁrst need help and training
about risk perception, communication and
management if they are to be useful in helping
consumers come to satisfactory decisions.
Modern public health inﬂuences
on the doctor–patient relationship
There is a wider context and inﬂuence.
Throughout history until comparatively
recently, the clinical encounter was initiated by
the concerned individual with symptoms, who
sought the help of a medical practitioner. But
things have changed. Public health medicine and
epidemiological research have gone beyond
replacing a defective and contaminated Broad
Street London water pump, to the establishment
in the UK of extensive NHS prevention, vac-
cination and screening with the potential to
beneﬁt large sectors of the population. But when
health practitioners are provided with incentives,
or are set percentage targets to ensure viability
of national programmes, in a reversal of the
usual doctor–patient relationship, relationships
sometimes become strained in this atmosphere
of ‘coercive healthism’.5 Medical screening has
been described as ‘institutionalisation of risk’.6
The ‘relationship-reversal’ turns citizens into
patients. Individuals who sought reassurance
ﬁnd themselves having to make very diﬃcult risk
Box 1 Our understanding of the terms used in this paper:
• Patients – people using health-care services for
health problems or conditions
• Consumers – people using or offered health-care
services,
• Citizens – the general public not immediately using
health-care services
• Patients’ associations – individuals coalescing to
support patients with a or certain condition(s)
• Consumer representative (or groups) – individual
consumers (or groups) working to enhance health-
care quality for patients or consumers or citizens
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assessments – many then regret having respon-
ded to persuasive invitations to present them-
selves for screening. This has had important
ethical, psychosocial, epistemological, economic,
political and policy implications, with conse-
quences and repercussions. One of the repercus-
sions has been to cause a shift in perceptions of
the ‘usual’ doctor–patient relationship.
Need for research: Department of Health
‘Health in Partnership’ (HiP) Programme
The UK Department of Health recognized that
a thorough research exploration of the primary
encounter in the ‘usual doctor–patient rela-
tionship’ was needed. Such research might
provide evidence that could be a basis for con-
sultation approaches that accommodated more
closely the desires of both parties in the process,
and encompassed and met a wide variety of
needs and aspirations in a multiplicity of
contemporary settings. It might also provide
evidence to improve training programmes.
Crucially, developments in the way health care
is delivered needed to take account of the range
of views held by diﬀerent people. The UK
Department of Health commissioned a pro-
gramme of research entitled ‘Health in Part-
nership’, and here we present an overview of
one of these studies, drawing together partic-
ularly the ﬁndings about what patients in the
study reported as important. We will ﬁrst pre-
sent a summary of the study and its ﬁndings,
and then reﬂect on relevance to the conceptual
developments noted above regarding patient
involvement in research.
The ‘Health in Partnership’ study of SDM7
This study was undertaken in Wales by a
multidisciplinary group of researchers including
GPs (including AE and GE), a research oﬃcer, a
statistician, a research psychologist, a professor
of health services research, health economists,
ﬁve members of a school of care sciences (prin-
cipally nursing), and an independent advocate
for quality in research and healthcare (HT). The
latter was founding chairman of the Consumers’
Advisory Group for Clinical Trials (CAG-CT).
The Study Steering Group thus comprised 18
members from a diversity of disciplines. In
addition, there were nine other contributors to
speciﬁc parts of the study, including sociologists,
GPs, a health-care scientist, a decision-making
research specialist and a representative from a
patients’ association. The participants in the
study itself were 20 GPs from Gwent, their
practice staﬀ, and almost 800 patients at these
practices. The Gwent Local Research Ethics
Committee approved the study. Regardless of
amount of input, the contribution of every
individual was viewed as equal in weight and a
necessary component of the study. This paper
later summarizes some of the research ﬁndings
that are relevant to these reﬂections on patient
and consumer participation in the research
process. The full details and publications arising
from the study are available at: http://www.
healthinpartnership.org/studies/edwards.html.7
Consumer contribution
Patient and consumer groups or representatives
were engaged at several stages of the research
process from inception to completion. These are
listed in Table 1. The consumer representatives’
contribution came primarily from the CAG-CT,
which also provided the individual ‘advocate’ to
contribute to the study Steering Group. This
contribution will therefore be described in some
detail.
The CAG-CT was involved from the pre-trial
phase, and contributed to protocol development
and one of the early developmental focus
groups.8 This developmental work (with 47
consumer and patient focus group participants)
explored the important outcomes for patients,
when considering decision-making approaches,
information availability and involvement. Views
of users and professionals are equally important
in arriving at conclusions about shared decision-
making. It was important to establish their
degree of congruence by using rigorous qualit-
ative research methods that also took account of
possible biases.9,10 The focus group participants
identiﬁed many aﬀective outcomes that were
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consistent with current literature trends. How-
ever, many cognitive and behavioural outcomes
that had been assessed in the literature were not
thought to be important by the focus group
participants. Importantly, a broader range of
outcomes than was evident in the literature of
the time was viewed as important to partici-
pants. These included feeling respected as a
‘player’ who has made a meaningful contribu-
tion to the discussion in the decision-making
process; the need for available and accessible
extra information sources for better assessment
of the information given; the opportunity for
involving others; continuity of care, including
clear arrangements for review of treatment
decisions.8,3,11
The importance of pre-trial qualitative
research
This conﬁrms the importance of undertaking
qualitative research with consumers before
completing a study outline and undertaking
collaborative preliminary work with consumers
in order to reﬁne both the interventions and
intended outcome measures. These strategies
make the proposed research more rele-
vant.25,26,12,13 The ethos of the CAG-CT, a joint
facilitative, working group of health profes-
sionals and consumers, rendered it the ideal
consumer group to be involved in the prelimin-
ary exploration of a trial question. Not only was
it familiar with engaging in iterative discussion
for research processes as a small mixed group,
for which it had received endorsement14,15 but it
could also provide consumer members for the
focus group work who had had practical
experience and enjoyed this type of iterative
working within a research project. For example,
the multi-centre trial of hormone replacement
therapy (HRT) in women with early breast
cancer was informed by a research project and
feasibility study planned and undertaken by the
CAG-CT in 1995.16 In this project, the focus
group work, facilitated by the King’s Fund,
London, identiﬁed and prioritized the desired
outcomes of patients, researchers and clinicians,
now included in the main multi-centre HRT trial
protocol.17 It also identiﬁed the speciﬁc training
needs for those who would run the trial and the
information needs of the participants, patients
and health professionals. The focus group pro-
cess was one of clear ground rules and meth-
odology for arriving at prioritization, enabling
satisfactory and equitable input from a very
mixed group of researchers, clinicians, patients
and advocates. These principles were modelled
again in the ‘Health in Partnership’ study of
SDM.7 After the initial inductive stages, patients
and consumers were actively engaged at all fur-
ther stages, including ﬁrst the development of
outcome measures. The further stages of the
research itself at which patient or consumer data
were evaluated are listed in Table 2, and will
now be addressed in turn.
Consumer and patient involvement
in developing outcome measures
in the Welsh Study
The objective of this stage was to develop and
validate an instrument that addressed the
range of outcomes identiﬁed by users as
important,8 some of which might be diﬃcult to
Table 1 The contribution of consumers to the different stages of the research
Stage of research process Contribution of consumers to research
Setting research questions Advocate engaged; consumer representatives and groups engaged in qualitative research8
Protocol design Advocate and patient association groups involved in formulation and drafting
Acquisition of funding Advocate and patient association groups involved as co-applicants
Implementing methodology Advocate engaged as trial scrutineer
Interpretation of results Advocate involved as Steering Group member for analysis and interpretation
Dissemination for policy and
practice
Advocate involved in publicity, publications and presentations at press and
scientiﬁc meetings
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measure or to assign appropriate weight to.18
Consumers and patients were involved in the
piloting and revision of the instrument through
focus groups, one-to-one interviews after
completing questionnaires, and postal survey.
After a series of iterations a ﬁnalized instru-
ment was produced, known as ‘COMRADE’
(Combined Outcome Measure for Risk Com-
munication and Decision-making Eﬀective-
ness).11 The preliminary qualitative research
with patient and consumer focus groups had
thus not only informed the nature of the
interventions for the SDM trial but had also
informed the development of an outcome
measure to evaluate risk communication (RC)
and decision-making (training) eﬀectiveness in
UK primary care.
This work oﬀers a model for undertaking
qualitative research in collaboration with ‘real
patients and consumers’, both before setting
up a randomized controlled trial, throughout,
and post-trial, including the development of
evaluation instruments and their use.11
Improvements in undertaking satisfactory
consultations depend on the availability of
sensitive measurement instruments to measure
what is being achieved. Crucially, the ‘success’
of this type of research should be interpreted
and judged, not just against biomedical tar-
gets, but also against criteria that patients have
identiﬁed. If delivery of patient-centred health
care is to become a reality, and satisfactory
decisions achieved, it is vital to know what
citizens value most when they become patients,
and to be able to measure accurately and
reliably.
Health economic methods
to assess patient preferences
Extending the patient ‘level’ evaluations, a
multi-level analysis of data derived from ques-
tionnaires administered 6 months after a study
consultation to 757 patients revealed the attrib-
utes within a consultation that patients valued
most.19 This data was derived by a discrete
choice experiment with a design derived from
Conjoint Analysis methods. It assesses strengths
of preference, by quantitative methods, for var-
ious ‘attributes’ – in this case, attributes of
consultations such as time, information,
involvement in decision-making etc. The attrib-
ute that patients valued most was that the doctor
listens, followed by ‘information easy to under-
stand’, ‘who chooses’, ‘amount of information’
and ‘length of consultation’. In terms of
involvement in decision-making, patients most
preferred a consultation in which they contri-
buted but did not have sole responsibility for the
decision taken (shared model). Least preferred
were consultations where the doctor alone
makes the decisions (paternalistic). Signiﬁcantly,
patient preferences were inﬂuenced by whether
the patients’ doctors had received SDM or RC
training interventions prior to the study con-
sultation, suggesting that actual experience of
involvement leads to people valuing it more.
This section of work thus identiﬁed patients’
priorities in consultations in a quantitative way,
to complement other qualitative analyses. These
data may be able to contribute to health eco-
nomic analyses of further developments in
health-care provision (such as whether patient
Table 2 Methods used for different elements of the evaluation of this HiP Shared Decision Making study
Stage of study Method
Assessment of relevant patient-based outcomes:
pre-trial phase
Focus group study with patient and consumer representative groups
Piloting and evaluation of patient-based outcome
instrument (questionnaire)
Semi-structured interviews and quantitative (factor) analysis of patient
responses to questionnaire
Health economic analysis of patient preferences
and utilities
Quantitative (multi-level regression) analysis of patient responses to a
further questionnaire
Qualitative methods of further enquiry In-depth interviews with patients immediately after study consultations
Micro-analytic qualitative methods Discourse analysis of interviews with further patient sample
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involvement is ‘worth it’, or whether training
interventions are cost-eﬀective), and thus ensure
that appropriate consumer outcomes are avail-
able for any policy decisions that may subse-
quently be made.
Qualitative methods of further enquiry
Broader qualitative work in this study also
demonstrated that it is possible to enhance the
content of consultations and its perceived value
to both doctor and patient. One-to-one inter-
views with patients after study consultations
found that RC interventions to doctors sharp-
ened the focus of consultations, changed the
content of the consultation, and resulted in a
greater perception of decisions actually being
made in the consultation. Doctors and patients
often interpreted shared decision-making diﬀer-
ently: patients perceived few changes. In prac-
tice, doctors selectively applied SDM and RC
approaches as appropriate in each consultation.
These ﬁndings provided more detail on the
process of what was happening within consul-
tations, even when the outcomes were quite
resistant to change: global ‘satisfaction’ with
consultations was high before and after the
training interventions to doctors, as measured
quantitatively at group level. The ﬁndings pro-
vide empirical support for the theoretical and
ethical justiﬁcations for professional training
developments in communication skills. These
skill developments should be incorporated into
professional training, with emphasis on the
beneﬁt of their ﬂexible use and selective appli-
cation, so that GPs may be encouraged to persist
in their selective use in the consulting room.
Training is needed not only to improve doctors’
ability to engage in RC, but also to give them
conﬁdence to use it more widely, but selectively.
Micro-analytic qualitative methods
to examine patient perspectives
The last phase of the research was a post-con-
sultation detailed qualitative analysis of
accounts of newly presenting patients who had
engaged in consultations with GPs previously
trained in the use of SDM and risk communi-
cating skills.10 Analysis of interviews conducted
with this purposive sample was by a method
combining Discourse Analysis and Membership
Category Analysis. This method rests on the
principle that people are what they are as a
result of their activities. The consistent message
emerging from an interesting variety of dynam-
ics of consultations was that the doctor should
listen; take concerns seriously; and communicate
eﬀectively. Ultimate decisions were shown to be
dependent on a series of sequential decisions
each of which rely on the doctor’s involvement,
at diﬀerent levels. Patients continually expressed
alignment with the doctor, but also actively
retained their authority in the process. This
rigorous analytic method, examining the ‘nego-
tiation of meanings’, demonstrated how the
understanding of the nature of patient involve-
ment can be enhanced. It can feed into training
and skill development programmes, probably
mainly at post-graduate level, so that doctors
(and other health-care professionals) grasp both
the conceptual understanding, methods for
practical application, and patient perspectives
and desires from consultations.
Synthesis
There are signiﬁcant potential shifts in how
health care could be provided. We are in a
transition period between the old-style pater-
nalistic mode of consultation and prescribing to
the patient-centred shared decision-making
model and the wider use of RC tools in a sen-
sitively negotiated exchange of information.
Consumer or patient involvement is increasing,
although arguably from a very low base. How-
ever, data from patients in this Welsh ‘Health in
Partnership’ study7 indicate that once patients
have experienced involvement they place a
higher value on it – they will increasingly value it
in the future. Once involvement is desired, the
next (almost automatic) desire is for information
to support the decision-making. Qualitative data
here indicated that after interventions to
enhance RC, the consultations were more likely
to result in active decisions about treatment or
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care. However, this is not yet easy to deliver in
practice. Professionals need more training and
skill development. Information provision (for
both professionals and consumers) needs sub-
stantially more resources directed towards it.
But even with more information, the public’s
understanding of risk also leaves much to be
desired.20,21 Understanding must be facilitated
by balanced use of information already avail-
able, and must be explored sensitively in dis-
cussions between professionals and patients.22
The caring eﬀect of consultations must not be
neglected.
There are also risks for health-care systems,
which are at risk of becoming an industry rather
than a service. Achieving behavioural change in
the population is a major pre-occupation, fre-
quently undertaken with little understanding of
people’s motivations and needs.23, sometimes
with commercial and political rather than
patient-orientated objectives in mind. What is
needed now is not so much public understanding
of science as understanding of the public by
scientists.24
This brief description of a research project
attempts to show how the public can be engaged
successfully and in a responsible and respectful
partnership so that important consumer and
patient perspectives and outcomes are identiﬁed,
and used in a responsible and ethical manner.
This model of partnership was achieved by both
clinicians and researchers in this study exploring
shared decision-making and the use of risk
communicating tools in general practice.7 There
are other recent examples of similar research
partnership activity, employing entirely diﬀerent
methodologies.17,25,26 By addressing consumer
and patient concerns and identifying workable
solutions, it is possible to explore how the con-
ceptual developments (SDM) might be transla-
ted into the reality of clinical practice.
To date, health-care developments have
largely been led by policy-makers, professionals
and academics. It is not certain that they will
have always addressed the processes of care and
outcomes that are most important to citizens,
consumers or patients. Early qualitative work in
this study suggests the opposite. There needs to
be a fundamental realignment of research
development towards the values and needs of the
public. This research project attempted to do
this, with a view to ﬁndings being available for
future policy debates and developments. There
are a variety of ﬁndings from a variety of
methods in this project but each is important. At
a more immediate level, the ﬁndings are
important for consumers and patients who want
to be involved and feel respected for their par-
ticipation in health-care decision-making.8 At a
more global level it is also possible to envisage
how this may inﬂuence how risks are discussed,
interpreted, managed and perhaps therefore
‘governed’ in our society.
Conclusion
If we are to derive maximum beneﬁt from this
research work, with its multi-faceted consumer
and patient evaluations, it is important to
appreciate that responsibility for developing
satisfactory and satisfying consulting styles does
not rest solely with professionals. The experience
of user involvement was valued by all study
participants in this work. There is a responsi-
bility on both consumers and consumer groups,
and patients and patient groups, not only to
encourage professionals to practice in this way,
but to ensure that there is no misuse of these
approaches by those charged with the wider
governance of risk.24 This needs active, intelli-
gent promotion by patients and consumers (both
individual and group) if maximum return and
sound ethical practices are to be achieved from
the outlay for this research work. In turn,
recognition by policy-makers will also be
important, with active support to enable con-
sumer organizations to disseminate these ﬁnd-
ings and initiate action.
The main requirement for incorporating
users’ input into research is researchers who
believe that the validity of the work is enhanced
by ensuring that the voice of the patient has an
equal opportunity to be heard from inception
through to dissemination.25,26 It is essential that
all collaborators are able to engage in well-
facilitated respectful debate and iteration within
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sound methodologies so that no voice, including
the consumer’s, has greater weight than
another’s in deciding, for example, on methods
of outcome evaluation.27 More importantly, the
development and implementation of these ﬁnd-
ings requires attitudinal shifts in patients, pro-
fessionals, policy makers and purchasers, not in
isolation, but in acute awareness of the need to
identify and shoulder responsibilities together, in
respectful iteration and collaboration, to forge
new and better relationships. The evidence gen-
erated and subsequent decision-making is then
likely to be more balanced through not having
neglected to include important stakeholders in
the process. The goal of improving processes at
the focal point of care – the consultation – may
be much more attainable in this light.
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